Cite

HARVARD Citation

    Fuh, K. et al. (n.d.). O012/#352 Atezolizumab and bevacizumab in recurrent endometrial cancer: a phase II, multi institutional trial. International journal of gynecological cancer. p. A8. [Online]. 
  
Back to record